3 Hot Biotech Penny Stocks to Add to Your April 2022 Watchlist
There are many different stocks to choose from when investing looking for biotech penny stocks. As with any investment, you want to find stocks that are doing well and have a good track record of performance and growth. This can be done through research and understanding what you’re looking for in an investment.
When it comes to penny stocks in the biotech industry however, usually we have to take it a step further. So, what makes a biotech stock worth buying? There are a few key factors to look for when considering stocks in this industry.
Finding Biotech Penny Stocks to Buy
The first aspect to understand when looking for penny stocks to buy in the biotech sector is the company itself. Is it doing well and have they been profitable in the past? A good financial balance sheet is usually a great indicator of what the company could have in store.
The next aspect to consider is what pharmaceutical compounds the company has in its pipeline. This could be anything from a new cancer drug to a vaccine or a medical tech device. The potential for blockbuster drugs can send stocks soaring and it’s important to be on the lookout for these potential game changers.
Finally, you want to look at the competition in the biotech sector. This is an industry that is constantly evolving and growing so you want to make sure the company you’re investing in has a good chance of succeeding. With this in mind, let’s take a look at three biotech penny stocks that are climbing right now.
3 Biotech Penny Stocks to Watch in April 2022
- Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)
- Ardelyx Inc. (NASDAQ: ARDX)
- Ocugen Inc. (NASDAQ: OCGN)
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)
Tonix Pharmaceuticals is a penny stock that we have covered numerous times in the past few weeks. And again on April 4th, shares of TNXP stock managed to shoot up by over 4.8% at EOD. In the past month, we’ve seen TNXP stock climb by more than 14% and since late February by over 30%. So, why are we seeing such solid bullish sentiment with TNXP stock? The most recent news from the company came on March 31st.
On the 31st, the company announced that it would be targeting organ transplant rejection patients via a Phase 1 trial of its TNX-1500 compound. In addition to this, the company posted its financial results for Q4 2021 and the full 2021 year on March 14th. In the results, it announced a net loss of $29.6 million or $0.07 per share for the fourth quarter.
While this is disheartening, the company did not expect any revenue for the period. However, it did end the year with more than $178 million in cash on hand. So, while Tonix does leave a lot to be desired, the company is working hard to continue growing right now. Whether this makes it worth adding to your list of biotech penny stocks to watch, is up to you.
Ardelyx Inc. (NASDAQ: ARDX)
Another big gaining biotech penny stock today is ARDX stock. By EOD, ARDX stock had shot up by more than 9% to over $1.17 per share. And, in the past month Ardelyx Inc. has seen its shares climb by more than 20%, which is no small feat. The big news for the company came today as it announced the U.S. launch of its IBSRELA treatment for IBS-C in adults.
“Innovative, novel therapies are needed in IBS-C due to the heterogeneous nature of the condition and the large proportion of patients who continue to suffer despite treatment.
The launch of IBSRELA, a first-in-class NHE3 inhibitor, provides a new treatment option with a novel mechanism of action and impressive efficacy data to address the constipation and multiple abdominal symptoms commonly seen in patients with IBS-C, as demonstrated in the Phase 3 clinical trials.”Anthony Lembo, M.D., the Director of the GI Motility and Functional Bowel Disorders Program at Beth Israel Deaconess Medical Center
While this is just the beginning for this potentially life-changing product, it is without a doubt, an exciting prospect for Ardelyx and investors alike. So, with this in mind, does ARDX stock deserve a spot on your penny stocks watchlist or not?
Ocugen Inc. (NASDAQ: OCGN)
Ocugen Inc. is another penny stock that we have been covering for quite some time. And with over 4.5% in gains by EOD on April 4th, it’s clear that OCGN stock is in focus once again. In the past month, OCGN stock has seen over 38% in gains, which is one of the main reasons that so many investors are paying attention to it right now. The most recent news from the company came on April 1st when it announced that it dosed its first patient in the Phase 1/2 clinical trial of its gene therapy candidate OCU400. This is a treatment for those suffering from inherited retinal degeneration.
“Everyone at Ocugen is excited about this important milestone. Every day, our teams are working toward developing a therapeutic for people who have no options when facing inherited retinal diseases. The first phase of the study is a safety evaluation of the product, eventually progressing into an efficacy study in patients. Today’s announcement signifies a first and monumentally critical step forward in achieving our mission to cure blindness diseases.”The CEO and Co-Founder of Ocugen, Dr. Shankar Musunuri
Right now, there is a major amount of focus on biotech stocks, and Ocugen is definitely one to watch. So, do you think it will be on your list of penny stocks moving forward or not?
Which Biotech Penny Stocks Are You Watching Right Now?
Finding the best biotech penny stocks to buy can be challenging. However, because there is such a wide breadth of choices, it all comes down to you and your investing style.
[Read More] No PHUN For DWAC Stock As Musk Invests In TWTR
While making money with penny stocks involves having a well-thought-out trading strategy, understanding how the market works will usually be a great first step. Considering this, which biotech penny stocks are you watching right now?
If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!!